Pharma Market Access
Northern Ireland: A case study for drug pricing controls vs free pricing
Generic drug manufacturers have warned that up to 90% of drugs currently supplied to Northern Ireland may be threatened with withdrawal as…
Pharmaceutical crisis deepens in Lebanon as central bank unable to meet cost of subsidized medicines
For international pharmaceutical companies, Lebanon has long been a small but important export market. Until recently, at around 50% of…
The UK’s first drug approval via Project Orbis – pulling away from the EMA strings?
In early May, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved a targeted anticancer drug, AstraZeneca's Tagrisso (osimertinib),…
Reference pricing in CEE countries puts downward pressure on prices
Pharmaceutical prices in central and eastern European (CEE) countries tend to be low and drop over time - a double…
US announces support of COVID-19 vaccine IP waiver
In a highly significant move, the US government has announced its backing for a waiver on intellectual property (IP) protection…